This week the European regulators recommended approval for the world’s first malaria vaccine. The World Health Organization will be the next body to evaluate its use. It will have to consider some major issues. It’s only about 30 percent effective. Its protection fades over time and it requires four doses over 18 months.CCTV’s Susan Roberts spoke with Joel Selanikio. He’s the CEO of Magpi– which develops and promotes new technologies for health and international development.
Joel Selanikio on effectiveness of malaria vaccine
Read Next: X